48 results on '"Uhl, Kathleen"'
Search Results
2. Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development
3. High-Cost Generic Drugs — Implications for Patients and Policymakers
4. Increasing Participation of Women in Early Phase Clinical Trials Approved by the FDA
5. Assessing proarrhythmic potential of drugs when optimal studies are infeasible
6. Burden of Changes in Generic Pill Appearance
7. Development of performance matrix for generic product equivalence of acyclovir topical creams
8. Ensuring the Safe and Effective Use of Medications During Pregnancy: Planning and Prevention Through Preconception Care
9. Thalidomide Use in the US: Experience with Pregnancy Testing in the S.T.E.P.S.® Programme
10. Drug eluting stents and the critical path initiative: Evolving paradigms for safety evaluation
11. Pregnancy Exposure Registries
12. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors
13. Risk Management Strategies in the Physicians’ Desk Reference Product Labels for Pregnancy Category X Drugs
14. SYSTEMIC LUPUS ERYTHEMATOSUS
15. CONTRIBUTORS
16. GOUT
17. Adverse effects in women: implications for drug development and regulatory policies
18. New precompetitive paradigms: Focus on cardiac safety
19. Conducting Clinical Pharmacology Studies in Pregnant and Lactating Women
20. Assessing sex differences: methodological considerations
21. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools†‡§
22. Antibiotic Use in Pregnancy and Lactation: What Is and Is Not Known About Teratogenic and Toxic Risks
23. Neonatal Signs After In Utero Exposure to Selective Serotonin Reuptake Inhibitors
24. Advanced Science Education in the Regulatory Arena: The Center for Drug Evaluation and Research Experience at the Food and Drug Administration
25. Generic Drugs: Expanding Possibilities for Clinical Pharmacology
26. CHAPTER 76 - SYSTEMIC LUPUS ERYTHEMATOSUS
27. CHAPTER 75 - GOUT
28. An Innovative Approach to Determine Fetal Risk: The FDA Office of Women's Health Pregnancy Exposure Registry Web Listing
29. 2018: A year of Advancing Generic Products and Policies, Laying the Foundation for 2019.
30. The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy
31. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools
32. Drug Use in Pregnancy and Lactation 1. Activities at FDA: Drug Use in Pregnancy and Lactation
33. RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL OF DAILY ORAL AZITHROMYCIN IN ADULTS FOR THE PROPHYLAXIS OF PLASMODIUM VIVAX MALARIA IN WESTERN THAILAND
34. Conclusions and Recommendations of the Expert Panel: Technical Workshop on Human Milk Surveillance and Biomonitoring for Environmental Chemicals in the United States
35. Human Milk Biomonitoring Data: Interpretation and Risk Assessment Issues
36. CONCLUSIONS, RESEARCH NEEDS, AND RECOMMENDATIONS OF THE EXPERT PANEL: TECHNICAL WORKSHOP ON HUMAN MILK SURVEILLANCE AND RESEARCH FOR ENVIRONMENTAL CHEMICALS IN THE UNITED STATES
37. Risk management of marketed drugs: FDA and the interface with the practice of medicine
38. Pancreotoxicity of Propofol Sedation during Purulent Meningitis.
39. Letters to the Editor.
40. How the FDA Ensures High-Quality Generic Drugs.
41. 2017 Was Another Record-Setting Year for Generic Drugs.
42. Disease Modifying Antirheumatic Drugs and Pregnancy
43. Complex Clinical, Legal, and Ethical Issues of Pregnant and Postpartum Women as Subjects in Clinical Trials.
44. Information on Medication Use in Pregnancy.
45. Letters to the Editor.
46. Accurate information on drug effects on pregnancy is crucial.
47. Conclusions, research needs, and recommendations of the expert panel: technical workshop on human milk surveillance and research for environmental chemicals in the United States.
48. Medications and breastfeeding.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.